EUVIMEDEUVIMED entdecken
Open Access

Nanoscale covalent organic framework-mediated pyroelectrocatalytic activation of immunogenic cell death for potent immunotherapy

Xingguang Li iD, Meng-Lu Gao iD, Shan-Shan Wang iD, Yizhi Hu iD, Dongzhi Hou iD, Pei-Nian Liu iD, Huijing Xiang iD

Science Advances · 29.11.2024 · 10 (48)

DOI: 10.1126/sciadv.adr5145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 29.11.2024. Verfasst von Xingguang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Functional Materials Chemistry, Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East…. Hauptthemen laut MEDLINE: Immunotherapy, Immunogenic Cell Death. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The conventional molecular immunogenic cell death (ICD) inducers suffer from poor biocompatibility and unsatisfactory efficacy. Here, a biocompatible nanosized covalent organic framework (nCOF)–based pyroelectric catalyst (denoted as TPAD-COF NPs) is designed for pyroelectric catalysis-activated in situ immunotherapy. TPAD-COF NPs confine organic pyroelectric molecules to rigid TPAD-COF NPs to substantially reduce aggregation and enhance biocompatibility, thus improving pyroelectrocatalytic efficiency. After tumor internalization, TPAD-COF NPs facilitate photothermal tumor ablation under near-infrared (NIR) laser exposure, resulting in effective ICD induction. In addition, TPAD-COF NPs effectively catalyze the conversion of temperature changes to pyroelectric changes, which subsequently react with adjacent O 2 to generate reactive oxygen species, thus triggering robust ICD activation. In vivo evaluation using mouse models confirmed that TPAD-COF NPs evidently inhibited the proliferation of primary and distant tumors and prevented lung metastasis under NIR laser illumination. Therefore, this study opens an avenue for designing nCOF-based catalysts for pyroelectric catalysis-activated in situ immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyImmunogenic Cell DeathAnimalsMiceCatalysisCell Line, TumorHumansMetal-Organic FrameworksNanoparticlesReactive Oxygen Species

Substanzen

Metal-Organic FrameworksReactive Oxygen Species

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Functional Materials Chemistry, Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, 200237 China.
  • State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
  • School of Life Sciences, Shanghai University, Shanghai 200444, China.

ORCID-Profile: Xingguang Li, Meng-Lu Gao, Shan-Shan Wang, Yizhi Hu, Dongzhi Hou, Pei-Nian Liu, Huijing Xiang

Zitieren

APA

Li, X., Gao, M. L., Wang, S. S., Hu, Y., Hou, D., Liu, P. N., & Xiang, H. (2024). Nanoscale covalent organic framework-mediated pyroelectrocatalytic activation of immunogenic cell death for potent immunotherapy. Science Advances, 10(48). https://doi.org/10.1126/sciadv.adr5145

Vancouver

Li X, Gao ML, Wang SS, Hu Y, Hou D, Liu PN, et al. Nanoscale covalent organic framework-mediated pyroelectrocatalytic activation of immunogenic cell death for potent immunotherapy. Science Advances. 2024;10(48). doi:10.1126/sciadv.adr5145

BibTeX
@article{Li2024,
  author = {Li, Xingguang and Gao, Meng-Lu and Wang, Shan-Shan and Hu, Yizhi and Hou, Dongzhi and Liu, Pei-Nian and Xiang, Huijing},
  title = {Nanoscale covalent organic framework-mediated pyroelectrocatalytic activation of immunogenic cell death for potent immunotherapy},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {48},
  doi = {10.1126/sciadv.adr5145}
}
Kostenlos starten →